首页> 外国专利> GROUP OF GENES FOR MOLECULAR TYPING OF MEDULLOBLASTOMA AND USE THEREOF

GROUP OF GENES FOR MOLECULAR TYPING OF MEDULLOBLASTOMA AND USE THEREOF

机译:髓母细胞分子分型基因组及其用途

摘要

A group of genes for molecular typing of medulloblastoma, comprising the following 24 genes: EPHA7 gene, OTX2 gene, ROBO1 gene, TTR gene, LGR5 gene, IGF2BP3 gene, TBR1 gene, ZFPM2 gene, TRDC gene, TRAC gene, PEX5L gene, NKD1 gene, RALYL gene, GABRA5 gene, GAD1 gene, TNC gene, KCNA1 gene, EOMES gene, MAB21L2 gene, WIF1 gene, DKK2 gene, PDLIM3 gene, IMPG2 gene, and KHDRBS2 gene. Use of the described genes in the preparation of kits and gene chips for molecular typing of medulloblastoma. Upon verification, the described genes can accurately differentiate WNT type, SHH type, Group3 type and Group4 type of medulloblastoma, and the results are objective, and have high accuracy, and the experimental cycle is short, and thus the genes have important clinical significance for accurate treatment of a patient.
机译:髓母细胞瘤分子分型的一组基因,包括以下24个基因:EPHA7基因,OTX2基因,ROBO1基因,TTR基因,LGR5基因,IGF2BP3基因,TBR1基因,ZFPM2基因,TRDC基因,TRAC基因,PEX5L基因,NKD1基因,RALYL基因,GABRA5基因,GAD1基因,TNC基因,KCNA1基因,EOMES基因,MAB21L2基因,WIF1基因,DKK2基因,PDLIM3基因,IMPG2基因和KHDRBS2基因。所述基因在制备用于髓母细胞瘤分子分型的试剂盒和基因芯片中的用途。经验证,所描述的基因可以准确地区分髓母细胞瘤的WNT型,SHH型,Group3型和Group4型,结果客观,准确度高,实验周期短,因此对于临床具有重要的临床意义。准确治疗病人。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号